皇家制药版税 RPRX
$67.30 −$0.27 (-0.40%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $68.80 +2.23%
开盘$66.52
昨收$67.57
当日区间$66.52 – $68.15
成交量4.84M
市值$29.97B
市盈率（TTM）44.0
股息率1.37%
基本面
最新报告季度：Q2, ended Jun 2026
营收$674.14M+16.5% YoY
营业利润$133.12M-36.5% YoY
净利润$81.49M-12.0% YoY
摊薄每股收益$0.04-42.9% YoY
自由现金流$728.46M+100.1% YoY
经营现金流$728.46M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
营业利润率62.3%
净利率32.0%
净资产收益率12.3%
资产收益率4.3%
投入资本回报率7.6%
流动比率2.80
负债/资产比率50.6%
现金及投资$1.73B
总负债$8.96B
净现金（净负债）-$7.24B
自由现金流/营收117.4%
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $674.14M | – | $2.38B | $621.99M | $609.29M |
| 营业总收入 | $674.14M | $630.58M | $2.38B | $621.99M | $609.29M |
| 营业费用 | $541.02M | -$1.91M | $818.68M | $233.61M | $182.14M |
| 销售及管理费用 | $161.89M | $159.49M | $573.48M | $164.27M | $118.73M |
| -管理费用 | $161.89M | $159.49M | $573.48M | $164.27M | $118.73M |
| 研发费用 | $97.85M | $39.79M | $452.00M | $50.50M | $50.50M |
| 资产减值损失 | $13.07M | -$3.70M | $89.03M | -$4.27M | $766,000.00 |
| 其他营业费用 | $268.22M | -$197.49M | -$295.84M | $23.11M | $12.14M |
| 营业利润 | $133.12M | $632.48M | $1.56B | $388.38M | $427.16M |
| 非经营性利息净收入（支出） | -$88.49M | -$87.49M | -$274.07M | -$87.10M | -$72.66M |
| 非经营性利息收入 | $5.13M | $6.23M | $33.59M | $7.07M | $6.90M |
| 非经营性利息支出 | $93.62M | $93.72M | $307.66M | $94.17M | $79.56M |
| 其他收入（支出） | $36.86M | -$76.73M | $38.75M | $54.63M | $89.72M |
| 证券出售收益 | $34.28M | -$26.85M | $24.01M | $58.80M | $75.34M |
| 权益法投资收益 | $4.08M | $21.76M | $29.09M | $4.01M | $15.95M |
| 特殊收益（费用） | $0.00 | -$69.44M | – | – | – |
| -减：核销 | $0.00 | $69.44M | – | – | – |
| 其他非经营性收入（支出） | -$1.50M | -$2.20M | -$14.35M | -$8.17M | -$1.58M |
| 税前利润 | $81.49M | $468.26M | $1.32B | $355.91M | $444.21M |
| 税费 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 净利润 | $81.49M | $468.26M | $1.32B | $355.91M | $444.21M |
| 持续经营利润 | $81.49M | $468.26M | $1.32B | $355.91M | $444.21M |
| 少数股东权益 | $63.60M | $173.57M | $553.25M | $141.71M | $155.99M |
| 归属母公司净利润 | $17.88M | $294.69M | $770.95M | $214.21M | $288.22M |
| 归属普通股股东净利润 | $17.88M | $294.69M | $770.95M | $214.21M | $288.22M |
| 基本每股收益 | $0.04 | $0.67 | $1.79 | $0.50 | $0.67 |
| 摊薄每股收益 | $0.04 | $0.67 | $1.78 | $0.38 | $0.67 |
| 每股股息 | $0.24 | $0.24 | $0.88 | $0.22 | $0.22 |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $19.82B | $19.82B | $19.62B | $19.62B | $19.35B |
| 流动资产合计 | $1.76B | $1.43B | $1.53B | $1.53B | $1.85B |
| 现金及现金等价物与短期投资 | $1.73B | $1.39B | $1.49B | $1.49B | $1.82B |
| -现金及现金等价物 | $811.99M | $586.40M | $618.70M | $618.70M | $938.94M |
| -短期投资 | $914.45M | $801.74M | $873.19M | $873.19M | $876.17M |
| 应收款 | $31.47M | $27.51M | $29.32M | $29.32M | $28.90M |
| -其他应收款 | $31.47M | $27.51M | $29.32M | $29.32M | $28.90M |
| 其他流动资产 | $6.66M | $10.16M | $6.89M | $6.89M | $5.52M |
| 非流动资产合计 | $18.06B | $18.39B | $18.09B | $18.09B | $17.50B |
| 投资及预付款 | $17.07B | $17.39B | $17.09B | $17.09B | $16.49B |
| -可供出售证券 | $16.81B | $17.12B | $16.80B | $16.80B | $16.20B |
| -长期股权投资 | $261.97M | $265.70M | $289.97M | $289.97M | $290.96M |
| 商誉及其他无形资产 | $923.54M | $924.63M | $924.63M | $924.63M | $924.63M |
| -商誉 | $923.54M | $924.63M | $924.63M | $924.63M | $924.63M |
| 其他非流动资产 | $62.96M | $76.85M | $79.29M | $79.29M | $86.59M |
| 负债合计 | $10.03B | $9.88B | $9.91B | $9.91B | $9.73B |
| 流动负债合计 | $630.93M | $535.68M | $636.21M | $636.21M | $530.80M |
| 应付款 | $126.85M | $112.90M | $92.23M | $92.23M | $118.64M |
| -应付账款 | $35.57M | $25.48M | $19.40M | $19.40M | $41.42M |
| -应付股利 | $91.28M | $87.42M | $72.83M | $72.83M | $77.22M |
| 一年内应计费用 | $107.77M | $25.30M | $110.82M | $110.82M | $29.04M |
| 短期债务及融资租赁负债 | $380.00M | $380.00M | $380.00M | $380.00M | $380.00M |
| -一年内到期债务 | $380.00M | $380.00M | $380.00M | $380.00M | $380.00M |
| 其他流动负债 | $16.32M | $17.48M | $53.16M | $53.16M | $3.12M |
| 非流动负债合计 | $9.40B | $9.34B | $9.27B | $9.27B | $9.20B |
| 长期债务及融资租赁负债 | $8.58B | $8.58B | $8.57B | $8.57B | $8.57B |
| -长期债务 | $8.58B | $8.58B | $8.57B | $8.57B | $8.57B |
| 员工福利 | $713.22M | $648.67M | $577.87M | $577.87M | $502.94M |
| 其他非流动负债 | $108.02M | $117.79M | $120.84M | $120.84M | $126.94M |
| 股东权益合计 | $9.79B | $9.94B | $9.71B | $9.71B | $9.62B |
| 股东权益 | $6.83B | $6.89B | $6.48B | $6.48B | $6.41B |
| 股本 | $108,000.00 | $108,000.00 | $106,000.00 | $106,000.00 | $107,000.00 |
| -普通股 | $108,000.00 | $108,000.00 | $106,000.00 | $106,000.00 | $107,000.00 |
| 资本公积 | $4.38B | $4.38B | $4.12B | $4.12B | $4.11B |
| 留存收益 | $2.46B | $2.51B | $2.36B | $2.36B | $2.30B |
| 减：库存股 | $2.72M | $2.71M | $2.61M | $2.61M | $2.61M |
| 少数股东权益 | $2.95B | $3.05B | $3.24B | $3.24B | $3.21B |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | $728.46M | $718.23M | $2.49B | $827.15M | $702.62M |
| 持续经营经营活动现金流净额 | $728.46M | $718.23M | $2.49B | $827.15M | $702.62M |
| 持续经营净利润 | $81.49M | $468.26M | $1.32B | $355.91M | $441.21M |
| 持续经营损益 | -$669.70M | -$596.58M | -$2.31B | -$655.23M | -$667.10M |
| 折旧、折耗与摊销 | $1.29M | $1.17M | $3.85M | $1.20M | $1.28M |
| 其他非现金项目 | $826.00M | $925.16M | $3.40B | $932.16M | $892.36M |
| 营运资金变动 | $86.69M | -$80.42M | -$17.15M | $48.51M | -$50.88M |
| -应收款变动 | -$3.96M | $1.81M | -$2.36M | -$415,000.00 | -$1.16M |
| -应付账款及应计费用变动 | $90.60M | -$90.60M | -$4.99M | $53.24M | -$45.66M |
| -其他流动资产变动 | $1.01M | -$4.91M | -$7.45M | -$3.31M | -$3.05M |
| -其他流动负债变动 | -$954,000.00 | $13.28M | -$2.35M | -$1.01M | -$1.01M |
| 投资活动现金流净额 | -$229.72M | -$477.87M | -$1.61B | -$847.80M | -$958.31M |
| 持续经营投资活动现金流净额 | -$229.72M | -$477.87M | -$1.61B | -$847.80M | -$958.31M |
| 投资购置及出售净额 | -$216.19M | -$470.17M | -$1.36B | -$850.08M | -$958.99M |
| 其他投资变动净额 | -$317,000.00 | -$50.00M | -$280.26M | -$2.71M | $0.00 |
| 筹资活动现金流 | -$273.15M | -$272.67M | -$1.19B | -$299.60M | $562.74M |
| 持续经营筹资活动现金流净额 | -$273.15M | -$272.67M | -$1.19B | -$299.60M | $562.74M |
| 普通股发行净额 | -$44.64M | -$50.10M | -$1.23B | -$80.54M | -$146.49M |
| 已付现金股利 | -$104.92M | -$104.49M | -$378.25M | -$94.34M | -$95.31M |
| 其他筹资费用净额 | -$123.59M | -$118.08M | -$534.81M | -$124.72M | -$149.94M |
| 期末现金余额 | $811.99M | $586.40M | $618.70M | $618.70M | $938.94M |
| 现金净变动 | $225.59M | -$32.30M | -$310.33M | -$320.25M | $307.04M |
| 期初现金余额 | $586.40M | $618.70M | $929.03M | $938.94M | $631.91M |
| 自由现金流 | $728.46M | $718.23M | $2.49B | $827.15M | $702.62M |
| 业务购买及出售净额 | – | – | -$74.42M | $0.00 | -$226,000.00 |
| 债务发行及偿还净额 | – | – | $954.48M | $0.00 | – |
暂无评论——快来第一个聊聊 RPRX。
登录后参与讨论。